Currently Viewing:
American Society of Clinical Oncology Annual Meeting
Persephone Trial: Cutting Trastuzumab Duration by Half Safer, Efficacious in HER2-Positive Breast Cancer
May 29, 2018
Remote Monitoring Can Reduce Radiation-Related Symptoms in Head and Neck Cancer
May 30, 2018
Despite USPSTF Recommendations, Lung Screening Rates Low Among Heavy Smokers
May 31, 2018
Nelarabine With Chemotherapy Boosted Outcomes in Pediatric and YA Patients With T-Cell Cancers
June 01, 2018
Dr Leonard B. Saltz on Deciding When a Patient Should Receive NGS Testing
June 02, 2018
Promising Early Phase Results With bb2121 CAR T Treatment in Relapsed Refractory Multiple Myeloma
June 02, 2018
Dr Peter Paul Yu Discusses the Impact of Health Information Technology in Oncology
June 02, 2018
Identifying Rational Immunotherapy Combinations for Glioblastoma: A Progress Report
June 02, 2018
Dr James Lin Chen Outlines Information Needs in Era of Precision Medicine
June 02, 2018
Ellen Miller Sonet Highlights Financial Burdens of Patients With Cancer
June 02, 2018
Utilization Management in Oncology: Current Strategies and a Path Forward
June 02, 2018
Immune Checkpoint Inhibitors Improve Outcomes in Mismatch Repair Deficient CRC, but Can Induce irAEs
June 02, 2018
ZUMA-1: Response to Axi-cel at Three Months Prognostic for Remission in B-cell Lymphoma
June 03, 2018
Cetuximab With Chemoradiation Worse Than Chemoradiation Alone in Older Patients With HNSCC
June 03, 2018
Dr Michael Thompson: The Role of Precision Medicine in the Community Setting
June 03, 2018
Dr Victoria Villaflor Outlines Challenges With Pursuing Precision Medicine
June 03, 2018
Clinical Trials: Sharing the Road With Real-World Evidence
June 04, 2018
Phase 3 TAILORx Results Confirm Chemotherapy Unnecessary in 70% of Women With Early-Stage Breast Cancer
June 04, 2018
KEYNOTE-042 Confirms First-Line Pembrolizumab Superior to Chemotherapy in PD-L1–Low Advanced NSCLC
June 04, 2018
Cemiplimab, in GOG 3016, Looks to Break New Ground for Immunotherapy in Cervical Cancer
June 04, 2018
Nearly Half of Patients With Metastatic CSCC Respond to Cemiplimab, on Fast Track at FDA
June 04, 2018
Opdivo Plus Chemo Boosts Progression-Free Survival 26% Over Chemo Alone in Late-Stage NSCLC
June 04, 2018
Managing Cancer-Related Pain in the Era of the Opioid Crisis
June 06, 2018
Currently Reading
Discussing the Cost Burden of Cancer With Patients
June 06, 2018

Discussing the Cost Burden of Cancer With Patients

Jaime Rosenberg
During a session at the 2018 American Society of Clinical Oncology Annual Meeting, June 1-5, in Chicago, Illinois, panelists discussed the financial burdens of cancer diagnosis and treatment, the barriers facing clinicians and patients in discussing these financial burdens, and solutions that can be implemented to alleviate the burden.
Patients with cancer often have medical bills and other health costs significantly higher than others. Now, with cancer drugs becoming increasingly more effective and more tolerable for patients, patients are on these drugs for longer periods of time, leading to increased financial burden, said Ryan Nipp, MD, MPH, Massachusetts General Hospital Cancer Center, during a session at the 2018 American Society of Clinical Oncology Annual Meeting, June 1-5, in Chicago, Illinois.

In addition to out-of-pocket costs, such as co-payments, deductibles, and prescriptions, patients with cancer often experience indirect financial issues during cancer treatment, including:
  • Employment issues: missed work, disability, job lock
  • Lifestyle factors: children’s education, mortgage/rent, basic living expenses
  • Concurrent issues: psychological distress, fear of the unknown, symptom burden.
Patients with cancer experience financial burdens related to the disease and its treatment across all insurance types at higher rates than those with other chronic conditions and those with no chronic conditions, explained Nipp; 43% of privately insured patients with cancer spend over 20% of their income on health-related spending, compared with 29.8% of those with another chronic condition and 16.4% of those with no chronic condition. For those with public insurance, 24% of patients with cancer spend over 20% of their income on health-related spending, compared with 18.7% and 5.8%, respectively.

“Increasingly, efforts are needed to foster appropriate patient–clinician communication about the cost of cancer care,” said Nipp. “Discussions between patients and clinicians about the costs of cancer care have the potential to improve care delivery and outcomes for patients by fostering informed decision making.”

However, there are numerous barriers facing both clinicians and patients, he explained. For clinicians, barriers include lack of knowledge about costs incurred by patients, potentially time-consuming discussions, concerns that cost information may encourage patients to forgo care, and concerns that cost discussions may jeopardize the patient–clinician relationship.

For patients, many feel unsure of the appropriateness of discussing costs with their clinician team and embarrassed or self-conscious to raise the issue; they also may have a desire to respect their clinician’s time, are not sure their clinicians would have a solution for the concern, or may prioritize other concerns during a time-limited visit.

Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare, followed up Nipp by asking the audience, “Have you ever made a major purchase without knowing the price, be it a car, camera, or computer? Because that’s what cancer patients do. They agree to a cancer treatment plan, and they don’t know what it will cost them.”

Until there are some policy solutions, it’s the problem of the patient and physician relationship, she said. She outlined different solutions that can be implemented to alleviate the burden facing these patients.

First, clinicians should determine who within their office will address the issues with patients. “I think that, very often, the physician thinks the nurse is doing it, the nurse thinks the office manager is doing it, and sometimes nobody’s doing it,” she said.

Other strategies highlighted by Sonet included ensuring patients know the major costs prior to treatment, considering lower-priced options and alternate dosing schedules, asking patients to discuss if treatment is too great a financial burden, and referring to financial and psychosocial counseling.

She also outlined resources available to patients, such as co-pay and patient assistance funds, hospital charity care, patient advocacy organizations, voluntary and faith-based resources within communities, and financial planning and insurance navigation.

CancerCare offers “A Helping Hand,” an online resource guide about financial assistance. There is a searchable database where patients can input a diagnosis and zip code and be presented with different resources available to them.

She also encouraged the use of patient portals for education and links. A patient will feel comfort knowing that if they’re up in the middle of the night worrying about something, they can go online to the website and learn about what's troubling them, she explained.  

“Patients’ learning styles may vary. Some people are visual learners, and some patients like to hear information. They will forget most of what their clinician tells them, because they’re anxious, and they’re upset, and they don’t really understand a lot of the information that’s being communicated,” Sonet said. “So, recognize that lots of different media can be very helpful.”

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up